MARKET

INSM

INSM

Insmed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

26.62
-1.59
-5.64%
After Hours: 26.70 +0.08 +0.30% 17:55 08/14 EDT
OPEN
27.94
PREV CLOSE
28.21
HIGH
28.46
LOW
26.52
VOLUME
1.35M
TURNOVER
--
52 WEEK HIGH
34.94
52 WEEK LOW
12.09
MARKET CAP
2.70B
P/E (TTM)
-10.0407
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average INSM stock price target is 45.25 with a high estimate of 56.00 and a low estimate of 35.00.

EPS

INSM News

More
Morgan Stanley Maintains Overweight on Insmed, Raises Price Target to $38
Morgan Stanley maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $35 to $38.
Benzinga · 4d ago
Insmed Incorporated (INSM) CEO William Lewis on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 6d ago
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
Insmed (INSM) delivered earnings and revenue surprises of -10.34% and 16.58%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/06 14:35
Insmed Reports Second Quarter 2020 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the second quarter ended June 30, 2020, and provided a business update.
PR Newswire · 08/06 11:30
Did Hedge Funds Make The Right Call On Insmed Incorporated (INSM)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional invest
Insider Monkey · 08/03 16:30
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:33
OSI Systems Receives $5 Million Order to Provide Medical Sensors
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Optoelectronics division has received an order for approximately $5 million from a leading healthcare original equipment manufacturer (OEM) to provide optical sensors fo
Business Wire · 07/28 12:30
OSI Systems Awarded $5 Million Contract to Develop Automated Detection of Biosecurity Risk Items
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Security division was awarded a contract from the Commonwealth Government of Australia represented through the Department of Agriculture, Water and the Environment ("DAW
Business Wire · 07/27 12:30

Industry

Biotechnology & Medical Research
-0.54%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Symbol
Price
%Change

About INSM

Insmed Incorporated is a global biopharmaceutical company. The Company’s product ARIKAYCE (amikacin liposome inhalation suspension) is developed for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The Company's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that offers a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.
More

Webull offers kinds of Insmed Incorporated stock information, including NASDAQ:INSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INSM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INSM stock methods without spending real money on the virtual paper trading platform.